TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
As of today, TG Therapeutics(TGTX) shares are valued at $61.80. The company's market cap stands at 9.36B, with a P/E ratio of 22.28.
During the trading session on 2026-10-31, TG Therapeutics(TGTX) shares reached a daily high of $61.90 and a low of $58.00. At a current price of $61.80, the stock is +6.5% higher than the low and still -0.2% under the high.
Trading activity shows a volume of 2.86M, compared to an average daily volume of 1.53M.
Over the past 52 weeks, TG Therapeutics(TGTX) stock has traded between a high of $61.90 and a low of $26.76.
Over the past 52 weeks, TG Therapeutics(TGTX) stock has traded between a high of $61.90 and a low of $26.76.
TGTX News
...
TG Therapeutics (TGTX) announced an update on their ongoing clinical study. The study, titled “Long-term Follow-up (LTFU) of Study Participants Who Received Az...
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.